Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Myeloproliferative Disorders 1Leukemia, Myeloid, Accelerated Phase 1

Interventions

Vincristine 5Methotrexate 5Dexamethasone 5Cytarabine 5Cyclophosphamide 5Inotuzumab Ozogamicin 4blinatumomab 3Rituximab 3Prednisone 3Doxorubicin 3venetoclax 2prednylidene 2pegaspargase 2merphos 2deltacortene 2Mercaptopurine 2Asparaginase 2olverembatinib 1ofatumumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1calaspargase pegol 1azathiopurine 1auricularum 1asparaginase erwinia chrysanthemi recombinant 1X-Rays 1Spinal Puncture 1Specimen Handling 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × olverembatinib × Clear all
NCT06754267 2024-12-31

Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL

First Affiliated Hospital of Zhejiang University

Phase 2 Recruiting
36 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡